[go: up one dir, main page]

GB201416605D0 - Combination therapy to reduce the risk of and to treat cancer - Google Patents

Combination therapy to reduce the risk of and to treat cancer

Info

Publication number
GB201416605D0
GB201416605D0 GB201416605A GB201416605A GB201416605D0 GB 201416605 D0 GB201416605 D0 GB 201416605D0 GB 201416605 A GB201416605 A GB 201416605A GB 201416605 A GB201416605 A GB 201416605A GB 201416605 D0 GB201416605 D0 GB 201416605D0
Authority
GB
United Kingdom
Prior art keywords
risk
reduce
combination therapy
treat cancer
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB201416605A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
EaglePharma Pty Ltd
Original Assignee
EaglePharma Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by EaglePharma Pty Ltd filed Critical EaglePharma Pty Ltd
Priority to GB201416605A priority Critical patent/GB201416605D0/en
Publication of GB201416605D0 publication Critical patent/GB201416605D0/en
Ceased legal-status Critical Current

Links

GB201416605A 2014-09-19 2014-09-19 Combination therapy to reduce the risk of and to treat cancer Ceased GB201416605D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB201416605A GB201416605D0 (en) 2014-09-19 2014-09-19 Combination therapy to reduce the risk of and to treat cancer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB201416605A GB201416605D0 (en) 2014-09-19 2014-09-19 Combination therapy to reduce the risk of and to treat cancer

Publications (1)

Publication Number Publication Date
GB201416605D0 true GB201416605D0 (en) 2014-11-05

Family

ID=51869188

Family Applications (1)

Application Number Title Priority Date Filing Date
GB201416605A Ceased GB201416605D0 (en) 2014-09-19 2014-09-19 Combination therapy to reduce the risk of and to treat cancer

Country Status (1)

Country Link
GB (1) GB201416605D0 (en)

Similar Documents

Publication Publication Date Title
IL268138A (en) Combinations of cabozantinib and atezolizumab to treat cancer
ZA201607415B (en) Antibody-drug-conjugate and its use for the treatment of cancer
IL256224B (en) Combination therapy for the treatment of cancer
IL248455A0 (en) Igf-1r antibody-drug-conjugate and its use for the treatment of cancer
PL3033086T3 (en) Combination therapy for the treatment of cancer
IL261959B1 (en) Treatment of cancer with tg02
SG11201609770TA (en) Combination therapies for the treatment of cancer
IL258521A (en) Combination therapy for the treatment of cancer
IL276733A (en) Use of eribulin in the treatment of cancer
SI3622953T1 (en) Combination treatment of cancer
IL275517A (en) Methods and combination therapy to treat cancer
EP3185884A4 (en) Combination therapy for treatment of cancer
PL3253208T3 (en) Combination therapies for use in the treatment of breast cancer
IL258494A (en) Rational combination therapy for the treatment of cancer
SG11201605745VA (en) Targeting clptm1l for treatment and prevention of cancer
GB201408297D0 (en) Treatment of cancer
GB201407837D0 (en) Methods of cancer therapy
GB201417456D0 (en) Treatment of cancer
GB201416605D0 (en) Combination therapy to reduce the risk of and to treat cancer
GB201410695D0 (en) Uses of oligouronates in cancer treatment
GB201418640D0 (en) Agents and methods for treatment of cancer
GB201317373D0 (en) Treatment and prevention of cancer
GB201409362D0 (en) Treatment of cancer
GB201405449D0 (en) Treatment of cancer
GB201405075D0 (en) Treatment of cancer

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)